One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
More than shots in the dark: improving patient stratification to move closer to personalised therapies in intrahepatic cholangiocarcinoma
doi : 10.1136/gutjnl-2023-331119
March 2024 - Volume 73 - 3
Advancing with cancer immunotherapeutics: CD29+Â regulatory T cell antagonism
Ebastine for the treatment of irritable bowel syndrome: old drug, new tricks?
EUS-guided gallbladder drainage in acute cholecystitis: long-term problems with surgical approach
Dupilumab demonstrated efficacy and was well tolerated regardless of prior use of swallowed topical corticosteroids in adolescent and adult patients with eosinophilic oesophagitis: a subgroup analysis of the phase 3 LIBERTY EoE TREET study
RE.GA.IN.: the Real-world Gastritis Initiative–updating the updates
Reducing scope 3 carbon emissions in gastrointestinal endoscopy: results of the prospective study of the ‘Green Endoscopy Project Würzburg’
Specific gut pathobionts escape antibody coating and are enriched during flares in patients with severe Crohn’s disease
Treatment of non-constipated irritable bowel syndrome with the histamine 1 receptor antagonist ebastine: a randomised, double-blind, placebo-controlled trial
Single-cell transcriptomic analysis deciphers heterogenous cancer stem-like cells in colorectal cancer and their organ-specific metastasis
Gut microbiota predicts severity and reveals novel metabolic signatures in acute pancreatitis
Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy
Immunosuppressive CD29+Â Treg accumulation in the liver in mice on checkpoint inhibitor therapy
Novel insights into causal effects of serum lipids and lipid-modifying targets on cholelithiasis
Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease
Early-life exposures and the microbiome: implications for IBD prevention
Haemorrhoidal disease reduces the risk of diverticular disease and irritable bowel syndrome: a Mendelian randomisation study
Over-the-scope clips versus standard therapy in upper gastrointestinal bleeding
Gastric cancer risk in autoimmune gastritis: evidence versus opinion
Significant underestimation of preventive effects in colorectal cancer screening trial
Correction:Â British Society of Gastroenterology guidelines on sedation in gastrointestinal endoscopy
